Influential Republican lawmakers have introduced companion bills in the U.S. House and Senate that call for a government report on [...] Read More »
Articles by : William Newton, Associate Editor/Senior Writer
New Medicaid Policy Change Could Reduce 340B Savings, Cause Drug Discontinuations, Warn Stakeholders
A Medicaid policy change that took effect at the start of 2024 could indirectly lead to lower 340B savings and [...] Read More »
A key healthcare committee in the Iowa House of Representatives recently introduced a bill that would bar drug manufacturer restrictions [...] Read More »
An influential senator’s inquiry into the nation’s two largest 340B pharmacy chains comes amid growing scrutiny into 340B contract pharmacies [...] Read More »
Pharmaceutical giant AbbVie recently urged a federal judge to rule on its suit against Louisiana’s 340B contract pharmacy law without [...] Read More »
The top Republican on an influential Senate committee yesterday asked the nation’s two largest contract pharmacy companies for detailed information [...] Read More »
Two high-ranking West Virginia state senators recently introduced a bipartisan bill that would prohibit drug manufacturer restrictions on 340B contract [...] Read More »
Rhode Island state lawmakers last week introduced bills that would prohibit both differentiated payments from pharmacy benefit managers (PBMs) to [...] Read More »
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...] Read More »
A senior Indiana state senator introduced a bill this week that would require 340B providers to annually report detailed financial [...] Read More »